Capabilities

We provide testing services to certify product and materials compliance, support quality control, and ensure the health and safety of workers and their environment. We provide assistance for clients who are not sure what tests they need. Our accredited materials characterization laboratory is the foundation of all the services of RJ Lee Group provides, including standardized testing for compliance, industrial hygiene and environmental analyses, quality control, and materials research and development.

We provide credentialed expertise supported by robust scientific data. We provide significant support to industrial clients for product development, industrial hygiene and overall production support.

RJ Lee Group maintains a visible and respected reputation within the legal community, having offered scientific support in civil litigation matters for nearly 30 years. 

  • Product Liability 
  • Toxic Tort
  • Construction Defect
  • Fugitive Emission
  • Personal Injury
  • Patent Infringement
  • Contract Disputes
  • Insurance Subrogation

Subject Matter Experts

From our core business of providing scientific solutions to our clients, we have developed innovative products. Some are produced internally, and some have arisen from partnerships with other research organizations. 

For example, we build lab software solutions to help manage and streamline your labs data, and environmental testing products for a variety of applications. 

  • IntelliSEM is a powerful automated particle analysis system.
  • ParticleID is  a customizable cloud hosted web application used to identify foreign particulate matter and  assist with root cause investigations. 

Other products we create count particles and help keep the air and environment safe.

RJ Lee Group is a materials analysis laboratory and consulting company which serves many different industries. We offer scientific solutions such as industrial forensics services, laboratory and testing services, litigation support, and laboratory software to many industries:

Shell Partners with RJ Lee Group to Test Employees for COVID-19

Dennis Hyde

November 3, 2020

With our nation’s largest construction and critical infrastructure projects returning to work, teamwork, data, and COVID-19 employee testing are keys to ensuring workplace safety. Accurate and sensitive viral testing helps large worksites to remediate and clean high-risk locations.

A $6 billion construction project in Beaver County, Pennsylvania, is almost back to full capacity. This 8,000 employee worksite was shut down in early spring, and getting the project running again was no small feat. But an on-site employee virus testing lab and rapid results allowed the site to continue adding workers through the summer. The mobile testing laboratory allowed for testing all employees, with results in just four hours, instead of several days or a week through traditional clinical laboratories. This capability gives the company a holistic view of employee population infection metrics by integrating sample analysis, tracking, and reporting. Rapid test results also assist with contact tracing, as the company can let close contacts know about positive virus testing results quickly.

Employee access to the worksite requires a negative COVID-19 test. After all employees have tested negative, testing is reserved for symptomatic employees, new hires, and those who show higher-than-normal temperatures at daily screenings. The company also offers a COVID-19 hotline if employees feel symptomatic outside of work, connecting associates with a clinical provider.

While not all worksites have the resources to develop on-site virus testing, a combination of the antigen and antibody tests that are now available have rapid turnaround times and should be included in smaller companies’ back-to-work strategies. Also, smaller facilities can focus on plant safety documentation or do smaller-scale on-site virus testing, with samples shipped offsite to a dedicated lab that offers 24-hour testing. While not as fast, dedicated testing can help facilities avoid the slow traditional health care supply chain and keep employees from having to leave work to test.

Operations such as refineries, food processing, manufacturing, and large-scale construction and government worksites are already learning to distance and revise processes to mitigate viral risk, but it still feels like the nation is in a limbo mode as we wait for a vaccine. “Wait for a vaccine” may be a long-term hope, not a short-term business strategy. Even as several drugs are in phase-3 testing trials, but trials may not prove efficacious, and it will take many months to manufacture and deliver enough doses for our population.

We could be living with this virus for much longer. Employee COVID-19 testing with quick turnaround times should be a part of back-to-work planning for major U.S. facilities to keep our nation producing, building, and thriving.

Related Posts